Trescot Andrea M
Pain and Headache Center, Anchorage, AK 99654, USA.
Best Pract Res Clin Anaesthesiol. 2014 Jun;28(2):153-66. doi: 10.1016/j.bpa.2014.03.004. Epub 2014 May 9.
The wide range of patient responses to surgical pain, opioids, and anesthetic agents has puzzled anesthesiologists for many years. Much of the variation has been attributed to differences in patient size, technique, or prior drug use. However, recent genetic testing has revealed exciting clues into the basis for these variances, allowing us to start to predict which patients may have difficulties and start to select medications more rationally. In this manuscript, we discuss genetics and pain perception, genetic predisposition to pain, drug metabolism interactions, ethnogenetics, opioid metabolism, opioid receptors, genetic-related peri-anesthetic toxicity, as well as a clinical approach and a discussion regarding the future of genetic testing and anesthesia.
患者对手术疼痛、阿片类药物和麻醉剂的反应范围广泛,多年来一直困扰着麻醉医生。这种差异很大程度上归因于患者体型、技术或既往用药情况的不同。然而,最近的基因检测揭示了这些差异背后令人兴奋的线索,使我们能够开始预测哪些患者可能会遇到困难,并开始更合理地选择药物。在本手稿中,我们讨论了遗传学与疼痛感知、疼痛的遗传易感性、药物代谢相互作用、种族遗传学、阿片类药物代谢、阿片受体、与遗传相关的围麻醉期毒性,以及关于基因检测和麻醉未来的临床方法和讨论。